Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway

Keyphrases

• SNAI1 100%
• Epithelial-mesenchymal Transition 100%
• Bleomycin-induced Pulmonary Fibrosis 100%
• Vincamine 100%
• TGF-1 40%
• P38 Mitogen-activated Protein Kinase (p38 MAPK) 40%
• ERK2 40%
• Fibronectin 30%
• B-cell Lymphoma 2 (Bcl-2) 20%
• Lung Tissue 20%
• Total Cell Count 20%
• N-cadherin 20%
• Cleaved caspase-3 20%
• Caspase-3 Protein 20%
• MDA Levels 20%
• LDH Activity 20%
• Signaling Pathway 10%
• Protective Behavior 10%
• Gene Expression 10%
• Quantitative PCR 10%
• Western Blotting 10%
• MRNA Level 10%
• Histopathological Examination 10%
• Anti-apoptotic 10%
• Respiratory Failure 10%
• Collagen 10%
• Idiopathic Pulmonary Fibrosis 10%
• Inflammatory Conditions 10%
• Bleomycin 10%
• Bronchoalveolar Lavage Fluid 10%
• Indole Alkaloids 10%
• P53 Expression 10%
• Protein Content 10%
• Vasodilator 10%
• Vinca Minor 10%
• Lung Disease 10%
• SOD Level 10%
• Masson's Trichrome Stain 10%
• Collagen Protein 10%
• Total Protein Content 10%
• Respiratory Death 10%
• Differential Cell Count 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Bleomycin-Induced Pulmonary Fibrosis 100%
• Vincamine 100%
• Mitogen Activated Protein Kinase 3 40%
• Fibronectin 30%
• Protein P53 20%
• Caspase 3 20%
• Lactate Dehydrogenase 20%
• Nerve Cell Adhesion Molecule 20%
• Inflammation 10%
• Enzyme-Linked Immunosorbent Assay 10%
• Western Blot 10%
• Antiapoptotic 10%
• Fibrosing Alveolitis 10%
• Respiratory Failure 10%
• Lung Disease 10%
• Bleomycin 10%
• Protein 10%
• Vasodilator Agent 10%
• Vinca 10%
• Indole Alkaloid 10%
• Messenger RNA 10%